Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00540475 · ClinicalTrials.gov registry record
Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT00540475: Completed study, sponsored by University of Pittsburgh.
NCT00540475 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00540475 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry (PA-IPF) is a cooperative project between five medical centers to coordinate a team of investigators. The aim of this registry will be: 1) To assess the extent of lung fibrosis in the commonwealth of Pennsylvania 2) To provide better access of patients with pulmonary fibrosis in all regions of Pennsylvania to standard of care and diagnosis 3) To facilitate the translation of new therapeutic interventions from the bench to the bedside.
Primary Outcome
Monitor IPF disease course
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2007-09 |
| Est. Completion | 2018-07 |
What the finished NCT00540475 record still lists
NCT00540475 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00540475 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00540475 about?
NCT00540475 is a clinical study titled "Pennsylvania Idiopathic Pulmonary Fibrosis Research Registry". The Pennsylvania Idiopathic Pulmonary Fibrosis State-wide Research Registry (PA-IPF) is a cooperative project between five medical centers to coordinate a team of investigators. The aim of this registry will be: 1) To assess the extent of lung fibrosis in the commonwealth of Pennsylvania 2) To provi...
What is the current status of trial NCT00540475?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2007-09. Estimated completion is 2018-07.
Who is sponsoring clinical trial NCT00540475?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia